Hai-Lian Shi Selected Research

Neuroinflammatory Diseases

4/2016	[Inhibitory effects of vina-ginsenoside R7 on activation of rat C6 astrocytes induced by LPS and TNF-α combination].
1/2016	Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway.
8/2014	Astragalosides from Radix Astragali benefits experimental autoimmune encephalomyelitis in C57BL /6 mice at multiple levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hai-Lian Shi Research Topics

Disease

4	Neoplasms (Cancer) 04/2023 - 11/2013
4	Stomach Neoplasms (Stomach Cancer) 06/2022 - 11/2013
3	Neuroinflammatory Diseases 04/2016 - 08/2014
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023 - 08/2014
2	Inflammation (Inflammations) 01/2017 - 08/2014
2	Body Weight (Weight, Body) 01/2017 - 01/2016
2	Neoplasm Metastasis (Metastasis) 12/2014 - 11/2013
1	Demyelinating Diseases (Demyelinating Disease) 01/2023
1	Motor Disorders 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2022
1	Wounds and Injuries (Trauma) 10/2017
1	Mucositis 01/2017
1	Diarrhea 01/2017
1	Weight Loss (Weight Reduction) 01/2017
1	Carcinogenesis 08/2016
1	Obesity 01/2016
1	Pain (Aches) 04/2015
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 04/2015
1	Neuroblastoma 07/2014
1	Hemorrhage 05/2014

Drug/Important Bio-Agent (IBA)

3	Interleukin-8 (Interleukin 8)IBA 08/2016 - 11/2013
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 06/2022 - 10/2017
2	Fluorouracil (Carac)FDA LinkGeneric 08/2021 - 01/2017
2	CytokinesIBA 01/2017 - 08/2014
2	BerberineIBA 08/2016 - 11/2013
2	evodiamineIBA 08/2016 - 11/2013
2	p38 Mitogen-Activated Protein KinasesIBA 08/2016 - 07/2014
2	Therapeutic UsesIBA 04/2016 - 07/2014
1	EstersIBA 04/2023
1	AbietanesIBA 04/2023
1	nepetaefolinIBA 04/2023
1	FlavonoidsIBA 01/2023
1	helichrysetinIBA 06/2022
1	Chalcone (Benzalacetophenone)IBA 06/2022
1	SodiumIBA 08/2021
1	galanginIBA 08/2021
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 08/2021
1	Proteins (Proteins, Gene)FDA Link 08/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017
1	Tuberculin (PPD)IBA 10/2017
1	Vancomycin FDA LinkGeneric 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	ChemokinesIBA 01/2017
1	Phosphotransferases (Kinase)IBA 08/2016
1	GlucocorticoidsIBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	LipidsIBA 01/2016
1	LeptinIBA 01/2016
1	CholesterolIBA 01/2016
1	astragaloside AIBA 01/2016
1	Transient Receptor Potential ChannelsIBA 04/2015
1	Serotonin (5 Hydroxytryptamine)IBA 04/2015
1	polygodialIBA 04/2015
1	Capsaicin (Zostrix)FDA Link 04/2015
1	Proteinase-Activated ReceptorsIBA 04/2015
1	RN 1747IBA 04/2015
1	Ruthenium RedIBA 04/2015
1	Huang QiIBA 08/2014
1	notoginsenoside Ft1IBA 07/2014

Therapy/Procedure

3	Therapeutics 08/2014 - 11/2013
1	Subcutaneous Injections 08/2021
1	Fecal Microbiota Transplantation 01/2017